knowledge -WSS

knowledge

author：hotspot 2025-08-11 09:46:17 - browse：2792

Illustration of a brain maze. -- biotech coverage from STAT — Adobe

The brain remains both the body’s most important organ and its least understood. But a draft atlas of the human brain published on Thursday gives scientists important insights into how it works and may pave the way for big advances in disease treatment and diagnosis.

This brain map, pieced together by hundreds of researchers from San Diego to Seattle to Stockholm, is essentially a cellular “parts list” of the human brain and a guide to how those pieces are arranged and work together. Scientists say that what they’ve already learned — including a stunning diversity of cell types in the brain — and what they’ll discover in the years to come will improve our understanding of deadly neurological diseases.

At the heart of this effort are some of biology’s most fundamental questions. How do mutations contribute to disease? What makes people different from one another? And what makes humans different from other primates?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： An inside look at PIPEs, biotech's buzzy new financing tool

explore

WSS

Federal weight loss drug coverage is 30 years out of date

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

AstraZeneca loses challenge to Medicare drug price negotiation

New weight loss drugs work. But how can they best be used?

The FDA must approve intranasal treatments for anaphylaxis

In search for therapies for solid tumors, companies turn to claudin

leisure time

knowledge

Wikipedia

Guidelines to prevent youth baseball injuries need more muscle

Clinical trials giant ICON acquires HumanFirst

United colonoscopy coverage change 'may cost lives,' doctors say

JPM: CVS says Medicare Advantage patients are impacting profits

Medicare details structure of new drug price negotiation program

Scientists unlock the key to scar

Medical leaders decry Supreme Court decision on affirmative action

Pfizer highlights cancer drugs it thinks could reignite investor interest

Guidelines to prevent youth baseball injuries need more muscle

Biotech companies concerned about China biosecurity crackdown

Wikipedia

How to address the problem of discarded donor organs

JPM: CVS says Medicare Advantage patients are impacting profits

In search for therapies for solid tumors, companies turn to claudin

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Feng Zhang, Grail founder join forces on new gene editing startup

J&J to buy cancer drug developer Ambrx Biopharma

leisure time

entertainment

explore

focus